Related references
Note: Only part of the references are listed.The prognostic roles of and correlation between ALK and MYCN protein expression in neuroblastoma
Hsiu-Hao Chang et al.
JOURNAL OF CLINICAL PATHOLOGY (2020)
Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project
Elizabeth Sokol et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Nomogram-based prediction of survival in unresectable or metastatic gastric cancer patients with good performance status who received first-line chemotherapy
Jin Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Trends in conditional survival and predictors of late death in neuroblastoma
Hannah E. Olsen et al.
PEDIATRIC BLOOD & CANCER (2020)
Combining Immunoscore with Clinicopathologic Features in Cholangiocarcinoma: An Influential Prognostic Nomogram
Zi-You Wu et al.
ONCOTARGETS AND THERAPY (2020)
Nomogram for predicting overall survival in children with neuroblastoma based on SEER database
Song-Wu Liang et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2020)
Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment
Sun Young Kim et al.
GASTRIC CANCER (2018)
Origin and initiation mechanisms of neuroblastoma
Shoma Tsubota et al.
CELL AND TISSUE RESEARCH (2018)
Clinical significance of MYCN amplification in patients with high-risk neuroblastoma
Ji Won Lee et al.
PEDIATRIC BLOOD & CANCER (2018)
Updates in Diagnosis, Management, and Treatment of Neuroblastoma
Caroline C. Swift et al.
RADIOGRAPHICS (2018)
Overview and recent advances in the treatment of neuroblastoma
Sarah B. Whittle et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Analysis of Recurrent Sacrococcygeal Teratoma in Children: Clinical Features, Relapse Risks, and Anorectal Functional Sequelae
Yi Wang et al.
MEDICAL SCIENCE MONITOR (2017)
Correlation between the International Neuroblastoma Pathology Classification and genomic signature in neuroblastoma
Atsuko Nakazawa et al.
CANCER SCIENCE (2015)
Nomograms in oncology: more than meets the eye
Vinod P. Balachandran et al.
LANCET ONCOLOGY (2015)
Childhood and adolescent cancer statistics, 2014
Elizabeth Ward et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project
Wendy B. London et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project
Herve J. Brisse et al.
RADIOLOGY (2011)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry
Alberto Garaventa et al.
EUROPEAN JOURNAL OF CANCER (2009)
Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma
Brian H. Kushner et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
Tom Monclair et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
How to build and interpret a nomogram for cancer prognosis
Alexia Iasonos et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients
Volker Strenger et al.
PEDIATRIC BLOOD & CANCER (2007)
The prognostic role of urinary catecholamines in infants with disseminated neuroblastoma may be mediated by MYCN amplification
Stefano Parodi et al.
PEDIATRIC BLOOD & CANCER (2007)
Revision of the international neuroblastoma pathology classification - Confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular
M Peuchmaur et al.
CANCER (2003)
Tumour markers are poor predictors for relapse or progression in neuroblastoma
T Simon et al.
EUROPEAN JOURNAL OF CANCER (2003)
Share Paper
